MétaCan
Menu
Back to cohort
Record W4407539510 · doi:10.1002/dmrr.70037

Association of GLP‐1 Receptor Agonists With Risk of Suicidal Ideation and Behaviour: A Systematic Review and Meta‐Analysis

2025· review· en· W4407539510 on OpenAlexaboutno aff
Ganesh Bushi, Mahalaqua Nazli Khatib, Mahendra Pratap Singh, Nidhi Uniyal, Suhas Ballal, Pooja Bansal, Kiran Bhopte, Manika Gupta, Abhay Gaidhane, Balvir Singh Tomar, Ayash Ashraf, Mohit Kumar, Ashish Singh Chauhan, Sanjit Sah, Hashem Abu Serhan, Muhammed Shabil

Bibliographic record

VenueDiabetes/Metabolism Research and Reviews · 2025
Typereview
Languageen
FieldMedicine
TopicDiabetes Treatment and Management
Canadian institutionsnot available
FundersQatar National Library
KeywordsMeta-analysisSuicidal ideationObservational studyPharmacovigilanceSystematic reviewMedicinePsychiatryInternal medicineMEDLINEClinical psychologyAdverse effectPoison controlInjury preventionEnvironmental healthBiology

Abstract

fetched live from OpenAlex

ABSTRACT Background and Objective Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) are widely used to treat type 2 diabetes and obesity, providing metabolic and cardiovascular benefits. However, concerns have emerged about potential neuropsychiatric side effects, including suicidal ideation and behaviour, prompting investigations by regulatory bodies such as the FDA and EMA. This systematic review and meta‐analysis aimed to assess the association between GLP‐1RA use and the risk of suicidal ideation or behaviour. Methods A systematic literature search was conducted in PubMed, Embase, and Web of Science through September 2024, adhering to PRISMA guidelines. Observational cohort and case‐control studies reporting suicidal ideation or behaviour in adults using GLP‐1RAs were included. The Modified Newcastle‐Ottawa Scale assessed risk of bias, and random‐effect models calculated risk ratios (RR) with 95% confidence intervals (CIs). Heterogeneity was assessed using the I 2 statistic. Results Of 126 studies, 11 were included from multiple countries with diverse designs. The meta‐analysis of four studies showed no statistically significant difference in suicidal outcomes between GLP‐1RA users and users of other anti‐hyperglycaemic drugs (RR: 0.568, 95% CI: 0.077–4.205). Substantial heterogeneity was observed (I 2 = 98%). Pharmacovigilance studies indicated no disproportionate increase in suicidality, while some observational studies suggested a lower risk. Conclusion This review found no significant link between GLP‐1RA use and increased suicidal ideation or behaviour. However, the high heterogeneity and reliance on pharmacovigilance data suggest caution. Clinicians should monitor patients, particularly those with psychiatric conditions, and further research is needed to assess long‐term neuropsychiatric safety.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.007
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.771
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0070.001
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0130.001
Bibliometrics0.0010.002
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.055
GPT teacher head0.380
Teacher spread0.325 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designSystematic review
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations20
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueDiabetes/Metabolism Research and ReviewsSame topicDiabetes Treatment and ManagementFrench-language works237,207